Associate Director, Global Business Development Forecasting

AbbVie•Mettawa, IL

5h•$141,500 - $268,500•Onsite

About The Position

Business Development is a critical pillar of AbbVie’s future growth, and Global Business Development Forecasting helps determine which external opportunities can create the greatest long-term value. The team brings commercial insight, analytical rigor, and strategic clarity to high-stakes BD decisions by translating science, market dynamics, competitive context, and uncertainty into actionable forecasts. The Associate Director plays a high-impact and highly visible role in this process, leading forecasts and commercial perspectives that shape executive understanding of opportunity value, risk, and strategic fit. Working across R&D, Commercial, Pipeline Commercial Strategy, CBSO, BD Finance, and other partners, this role sits at the intersection of scientific innovation and commercial strategy and directly supports decisions that influence AbbVie’s future portfolio. Success requires strong forecasting and commercial analytics expertise, rigorous assumption development, clear executive communication, and the ability to influence across a matrixed organization. Candidates should be curious, collaborative, comfortable with ambiguity, and able to create structure in fast-moving situations. For the right candidate, the role offers meaningful growth through exposure to senior leaders, enterprise-wide relationships, and deeper understanding of both R&D and Commercial strategy. This role reports to the Director, Global Business Development Forecasting.

Requirements

7+ years of relevant forecasting, market analytics, finance, or life sciences consulting experience in pharmaceutical, biotech, or related industries
Bachelor’s degree in finance/accounting or business required.
Experience building forecast models in Excel and forecasting platforms such as IQVIA Forecast Horizon
Ability to develop and/or utilize patient-flow modeling approaches, craft robust assumptions, and prepare evidence-based forecast inputs from epidemiology, secondary data, market research, treatment dynamics, competitive profiles, and expert input.
Demonstrated ability to clearly document forecast assumption logic and rationale.
Strong executive communication skills, including the ability to tailor messages by audience, translate complex quantitative analyses into recommendations and decision options, and influence stakeholders across functions and cultures without direct authority.
Strong project management skills in a fast-paced, ambiguous environment, with the ability to prioritize multiple workstreams, communicate trade-offs, escalate risks appropriately, and deliver high-quality work under time pressure.

Nice To Haves

MBA or other advanced degree preferred.
Familiarity with using and crafting Target Product Profiles (TPPs), establishing and aligning analytical business rules and market definitions, and leveraging claims data analytics is also highly desirable.
Experience supporting strategic decision making in specialized therapeutic areas such as Neuroscience, Immunology, Oncology, or other complex markets is preferred

Responsibilities

Lead commercial forecasting, market assessments, scenario analyses, and commercial P&Ls for BD opportunities, balancing analytical rigor with timely decision support in a fast-paced environment.
Develop patient-based forecast models, pressure-test assumptions, and apply primary research, secondary data, epidemiology, competitive intelligence, market access input, and expert perspectives to build a well-supported commercial view.
Partner broadly across BD, PCS, finance, market access, epidemiology, marketing analytics, and senior leadership to align assumptions, clarify risks and opportunities, and ensure commercial perspectives are reflected in deal valuation and governance discussions.
Translate complex analyses into clear recommendations, executive-ready narratives, and decision options for senior leaders and governance forums, facilitating productive discussion around uncertainty, trade-offs, and strategic implications.
Advance BD forecasting capabilities by sharing best practices, improving tools and processes, and helping create faster, more consistent, and audit-ready ways of working.